Letterio, John J.; Roberts, Anita B. (abril de 1998). "REGULATION OF IMMUNE RESPONSES BY TGF-β*". Annual Review of Immunology16 (1): 137–161. doi:10.1146/annurev.immunol.16.1.137.
Massagué, Joan; Xi, Qiaoran (4 de xullo de 2012). "TGF-β control of stem cell differentiation genes". FEBS Letters586 (14): 1953–1958. doi:10.1016/j.febslet.2012.03.023.
Li, Ming O.; Flavell, Richard A. (agosto de 2008). "TGF-β: A Master of All T Cell Trades". Cell134 (3): 392–404. doi:10.1016/j.cell.2008.07.025.
Massagué, Joan; Blain, Stacy W; Lo, Roger S (outubro de 2000). "TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders". Cell103 (2): 295–309. doi:10.1016/S0092-8674(00)00121-5.
Herpin A, Lelong C, Favrel P (2004). "Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans". Dev Comp Immunol28 (5): 461–85. PMID15062644. doi:10.1016/j.dci.2003.09.007.
Derynck R, Jarrett JA, Chen EY, et al. (1985). "Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells". Nature316 (6030): 701–5. PMID3861940. doi:10.1038/316701a0.
Murphy-Ullrich JE, Poczatek M (2000). "Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology". Cytokine Growth Factor Rev.11 (1-2): 59–69. PMID10708953. doi:10.1016/S1359-6101(99)00029-5.
Shull MM, Ormsby I, Kier AB, et al. (outubro de 1992). "Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease". Nature359 (6397): 693–9. PMID1436033. doi:10.1038/359693a0.
Selvaraj RK, Geiger T (marzo de 2008). "Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance". Journal of immunology180 (5): 2830–2838. PMID18292504. doi:10.4049/jimmunol.180.5.2830.
Nakahara J, Maeda M, Aiso S, Suzuki N (febreiro de 2012). "Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy.". Clinical reviews in allergy & immunology42 (1): 26–34. PMID22189514. doi:10.1007/s12016-011-8287-6.
Herpin A, Lelong C, Favrel P (2004). "Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans". Dev Comp Immunol28 (5): 461–85. PMID15062644. doi:10.1016/j.dci.2003.09.007.
Derynck R, Jarrett JA, Chen EY, et al. (1985). "Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells". Nature316 (6030): 701–5. PMID3861940. doi:10.1038/316701a0.
Murphy-Ullrich JE, Poczatek M (2000). "Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology". Cytokine Growth Factor Rev.11 (1-2): 59–69. PMID10708953. doi:10.1016/S1359-6101(99)00029-5.
Shull MM, Ormsby I, Kier AB, et al. (outubro de 1992). "Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease". Nature359 (6397): 693–9. PMID1436033. doi:10.1038/359693a0.
Selvaraj RK, Geiger T (marzo de 2008). "Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance". Journal of immunology180 (5): 2830–2838. PMID18292504. doi:10.4049/jimmunol.180.5.2830.
Nakahara J, Maeda M, Aiso S, Suzuki N (febreiro de 2012). "Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy.". Clinical reviews in allergy & immunology42 (1): 26–34. PMID22189514. doi:10.1007/s12016-011-8287-6.